Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol

por Enjoji, Munechika, Yasutake, Kenichiro, Kohjima, Motoyuki, Nakamuta, Makoto
Publicado 2012

Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments

por Enjoji, Munechika, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakamuta, Makoto
Publicado 2012

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A r...

por Kotoh, Kazuhiro, Enjoji, Munechika, Kato, Masaki, Kohjima, Motoyuki, Nakamuta, Makoto, Takayanagi, Ryoichi
Publicado 2008

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake

por Yasutake, Kenichiro, Kohjima, Motoyuki, Nakashima, Manabu, Kotoh, Kazuhiro, Nakamuta, Makoto, Enjoji, Munechika
Publicado 2012

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

por Kohjima, Motoyuki, Enjoji, Munechika, Higuchi, Nobito, Kotoh, Kazuhiro, Kato, Masaki, Takayanagi, Ryoiichi, Nakamuta, Makoto
Publicado 2007

Hepatocyte polarity establishment and apical lumen formation are organized by Par3, Cdc42, and aPKC in conjunction with Lgl

por Tocan, Vlad, Hayase, Junya, Kamakura, Sachiko, Kohda, Akira, Ohga, Shouichi, Kohjima, Motoyuki, Sumimoto, Hideki
Publicado 2021

Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods

por Nakamuta, Makoto, Kohjima, Motoyuki, Morizono, Shusuke, Yoshimoto, Tsuyoshi, Miyagi, Yuzuru, Sakai, Hironori, Enjoji, Munechika, Kotoh, Kazuhiro
Publicado 2006

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

por Enjoji, Munechika, Machida, Kazuyuki, Kohjima, Motoyuki, Kato, Masaki, Kotoh, Kazuhiro, Matsunaga, Kazuhisa, Nakashima, Manabu, Nakamuta, Makoto
Publicado 2010

Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines

por Takei, Ryoko, Inoue, Tomoaki, Sonoda, Noriyuki, Kohjima, Motoyuki, Okamoto, Misato, Sakamoto, Ryuichi, Inoguchi, Toyoshi, Ogawa, Yoshihiro
Publicado 2019

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-f...

por Hirayama, Takeshi, Ikegami, Tadashi, Honda, Akira, Miyazaki, Teruo, Yara, Sho-Ichiro, Kohjima, Motoyuki, Nakamuta, Makoto, Matsuzaki, Yasushi
Publicado 2017

Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin

por Fujino, Tatsuya, Nakamuta, Makoto, Aoyagi, Yoko, Kohjima, Motoyuki, Satoh, Takeaki, Fukuda, Mika, Ishibashi, Hiromi, Yatsuhashi, Hiroshi, Enjoji, Munechika
Publicado 2011

A high prevalence of extreme hyperferritinemia in acute hepatitis patients

por Kotoh, Kazuhiro, Ueda, Akihiro, Tanaka, Masatake, Miyazaki, Masayuki, Kato, Masaki, Kohjima, Motoyuki, Enjoji, Munechika, Nakamuta, Makoto, Takayanagi, Ryoichi
Publicado 2009

Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report

por KUWAYAMA, MIYUKI, UCHINO, KEITA, TAKAYOSHI, KOTOE, KOMODA, MASATO, KOHJIMA, MOTOYUKI, NAKAMUTA, MAKOTO, MOMOSAKI, SEIYA, KUSABA, HITOSHI, AKASHI, KOICHI, BABA, EISHI
Publicado 2016

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma

por Miyazaki, Masayuki, Yada, Masayoshi, Tanaka, Kosuke, Senjyu, Takeshi, Goya, Takeshi, Motomura, Kenta, Kohjima, Motoyuki, Kato, Masaki, Masumoto, Akihide, Kotoh, Kazuhiro
Publicado 2017

Microcirculatory disturbance in acute liver injury

por Kuwano, Akifumi, Kurokawa, Miho, Kohjima, Motoyuki, Imoto, Koji, Tashiro, Shigeki, Suzuki, Hideo, Tanaka, Masatake, Okada, Seiji, Kato, Masaki, Ogawa, Yoshihiro
Publicado 2021

Upregulated expression of hypoxia reactive genes in peripheral blood mononuclear cells from chronic liver disease patients

por Kuwano, Akifumi, Tanaka, Masatake, Suzuki, Hideo, Kurokawa, Miho, Imoto, Koji, Tashiro, Shigeki, Goya, Takeshi, Kohjima, Motoyuki, Kato, Masaki, Ogawa, Yoshihiro
Publicado 2021

Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency

por Imoto, Koji, Tanaka, Masatake, Goya, Takeshi, Aoyagi, Tomomi, Takahashi, Motoi, Kurokawa, Miho, Tashiro, Shigeki, Kato, Masaki, Kohjima, Motoyuki, Ogawa, Yoshihiro
Publicado 2022

Acute kidney injury is an unfavorable prognostic factor in acute liver failure and is associated with tumor necrosis factor-alpha

por Imoto, Koji, Tanaka, Masatake, Goya, Takeshi, Azuma, Yuki, Hioki, Tomonobu, Aoyagi, Tomomi, Takahashi, Motoi, Kurokawa, Miho, Kato, Masaki, Kohjima, Motoyuki, Ogawa, Yoshihiro
Publicado 2023

Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients

por Imoto, Koji, Kohjima, Motoyuki, Hioki, Tomonobu, Kurashige, Tomoyuki, Kurokawa, Miho, Tashiro, Shigeki, Suzuki, Hideo, Kuwano, Akifumi, Tanaka, Masatake, Okada, Seiji, Kato, Masaki, Ogawa, Yoshihiro
Publicado 2019

Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified

por Okuno, Hiroaki, Ogino, Haruei, Ihara, Eikichi, Nishioka, Kei, Tanaka, Yoshimasa, Chinen, Takatoshi, Kohjima, Motoyuki, Oono, Takamasa, Tanaka, Masatake, Goya, Takeshi, Fujimori, Nao, Iboshi, Yoichiro, Gotoda, Takuji, Ogawa, Yoshihiro
Publicado 2021